Benzyl 2-(butan-2-yl)-3-(hydroxymethyl)-5H,6H,7H,8H-imidazo[1,2-a]pyrazine-7-carboxylate

Catalog No.: 
ACWHLR240
CAS No.: 
2060050-91-9
Molecular Formula: 
C19H25N3O3
Molecular Weight: 
343.43
Benzyl 2-(butan-2-yl)-3-(hydroxymethyl)-5H,6H,7H,8H-imidazo[1,2-a]pyrazine-7-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$346.00InquiryInquiry
1g95%$989.00InquiryInquiry
5g95%$4896.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBenzyl 2-(butan-2-yl)-3-(hydroxymethyl)-5H,6H,7H,8H-imidazo[1,2-a]pyrazine-7-carboxylate
IUPAC Namebenzyl 2-(sec-butyl)-3-(hydroxymethyl)-5,6-dihydroimidazo[1,2-a]pyrazine-7(8H)-carboxylate
MDL No.MFCD30498464
Molecular FormulaC19H25N3O3
Molecular Weight343.43
SMILESO=C(N1CC2=NC(C(CC)C)=C(CO)N2CC1)OCC3=CC=CC=C3
InChI KeyJZTGUVAASLNIRQ-UHFFFAOYSA-N
SynonymImidazo[1,2-a]pyrazine-7(8H)-carboxylic acid, 5,6-dihydro-3-(hydroxymethyl)-2-(1-methylpropyl)-, phenylmethyl ester
CAS No.2060050-91-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACWHLR240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWHLR240 route product structure diagram
    ACWHLR2402060050-91-9
Inquiry

2. ACWHLR240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWHLR240 route product structure diagram
    ACWHLR2402060050-91-9
Inquiry

3. ACWHLR240 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWHLR240 route product structure diagram
    ACWHLR2402060050-91-9
Inquiry

Comments (0)